
Abigail Anne Risic
Examiner (ID: 17863, Phone: (571)270-7819 , Office: P/3671 )
| Most Active Art Unit | 3671 |
| Art Unit(s) | 3671 |
| Total Applications | 1365 |
| Issued Applications | 1003 |
| Pending Applications | 88 |
| Abandoned Applications | 311 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/980962 | Protamine-free insoluble acylated insulin compositions | Nov 14, 2001 | Abandoned |
Array
(
[id] => 5905817
[patent_doc_number] => 20020142347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Biosensor'
[patent_app_type] => new
[patent_app_number] => 09/987108
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21353
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142347.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987108
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987108 | Biosensor | Nov 12, 2001 | Abandoned |
Array
(
[id] => 6678873
[patent_doc_number] => 20030229014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Agents and methods for promoting bone growth'
[patent_app_type] => new
[patent_app_number] => 10/045673
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8583
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229014.pdf
[firstpage_image] =>[orig_patent_app_number] => 10045673
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/045673 | Agents and methods for promoting bone growth | Nov 8, 2001 | Issued |
Array
(
[id] => 5845281
[patent_doc_number] => 20020132776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Inhibitors of transglutaminase'
[patent_app_type] => new
[patent_app_number] => 10/004110
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9911
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004110
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004110 | Inhibitors of transglutaminase | Nov 1, 2001 | Abandoned |
Array
(
[id] => 6779354
[patent_doc_number] => 20030050436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Octapeptide bombesin analogs'
[patent_app_type] => new
[patent_app_number] => 10/004530
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12836
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004530 | Octapeptide bombesin analogs | Oct 22, 2001 | Abandoned |
Array
(
[id] => 6721290
[patent_doc_number] => 20030054979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom'
[patent_app_type] => new
[patent_app_number] => 09/981968
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10473
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981968 | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom | Oct 17, 2001 | Issued |
Array
(
[id] => 7450542
[patent_doc_number] => 20040010043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Treatment of cancers'
[patent_app_type] => new
[patent_app_number] => 10/398835
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5522
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20040010043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398835 | Treatment of cancers | Oct 11, 2001 | Issued |
| 09/958536 | Insulin crystals for pulmonary administration | Oct 10, 2001 | Abandoned |
Array
(
[id] => 6847343
[patent_doc_number] => 20030166510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Methods and compositions for increasing skin remodeling'
[patent_app_type] => new
[patent_app_number] => 09/976646
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5511
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166510.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976646 | Methods and compositions for increasing skin remodeling | Oct 10, 2001 | Abandoned |
Array
(
[id] => 6818229
[patent_doc_number] => 20030069187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Elastase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/972843
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3989
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069187.pdf
[firstpage_image] =>[orig_patent_app_number] => 09972843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/972843 | Elastase inhibitors | Oct 4, 2001 | Abandoned |
Array
(
[id] => 7412370
[patent_doc_number] => 20040176569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Regioselective liquid phase pegylation'
[patent_app_type] => new
[patent_app_number] => 10/398397
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3504
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176569.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398397
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398397 | Regioselective liquid phase pegylation | Oct 2, 2001 | Issued |
Array
(
[id] => 6769516
[patent_doc_number] => 20030215456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Method of treating cancer'
[patent_app_type] => new
[patent_app_number] => 09/969322
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35434
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215456.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969322 | Method of treating cancer | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6112512
[patent_doc_number] => 20020173451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Method of treating cancer'
[patent_app_type] => new
[patent_app_number] => 09/969244
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21914
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173451.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969244
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969244 | Method of treating cancer | Oct 1, 2001 | Abandoned |
Array
(
[id] => 6278517
[patent_doc_number] => 20020107202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Synthetic complementary peptides and ophthalmologic uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/967003
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8061
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107202.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967003 | Synthetic complementary peptides and ophthalmologic uses thereof | Sep 27, 2001 | Issued |
| 09/936793 | Proteins modified by xanthurenic acid | Sep 20, 2001 | Abandoned |
Array
(
[id] => 732905
[patent_doc_number] => 07037889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-02
[patent_title] => 'Pharmaceutical compositions for sustained drug delivery'
[patent_app_type] => utility
[patent_app_number] => 09/953247
[patent_app_country] => US
[patent_app_date] => 2001-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9915
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037889.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953247 | Pharmaceutical compositions for sustained drug delivery | Sep 12, 2001 | Issued |
Array
(
[id] => 6541738
[patent_doc_number] => 20020110561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Pharmaceutical composition having modified carrier'
[patent_app_type] => new
[patent_app_number] => 09/948827
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6027
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110561.pdf
[firstpage_image] =>[orig_patent_app_number] => 09948827
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/948827 | Pharmaceutical composition having modified carrier | Sep 6, 2001 | Abandoned |
Array
(
[id] => 6178552
[patent_doc_number] => 20020156234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Process for obtaining insulin precursors having correctly bonded cystine bridges'
[patent_app_type] => new
[patent_app_number] => 09/947563
[patent_app_country] => US
[patent_app_date] => 2001-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5351
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156234.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947563
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947563 | Process for obtaining insulin precursors having correctly bonded cystine bridges | Sep 6, 2001 | Issued |
Array
(
[id] => 1089344
[patent_doc_number] => 06828303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-07
[patent_title] => 'Prolonged delivery of peptides'
[patent_app_type] => B2
[patent_app_number] => 09/943084
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21754
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 500
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/828/06828303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09943084
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/943084 | Prolonged delivery of peptides | Aug 30, 2001 | Issued |
Array
(
[id] => 5788302
[patent_doc_number] => 20020160942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Echinocandin/carbohydrate complexes'
[patent_app_type] => new
[patent_app_number] => 09/942458
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10680
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160942.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942458
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942458 | Echinocandin/carbohydrate complexes | Aug 28, 2001 | Issued |